Gut healing and gastrointestinal repair benefit from direct peptide contact with digestive tissues
For someone already taking a GLP-1 medication, this reinforces the idea that obesity treatment is not cosmetic its a chronic disease treatment and risk-reduction medication. GLP-1s Users Had Lower Rates of Blood Clots, ER Visits, and Death The study analyzed health records from more than 26,000 adults with obesity and at least one autoimmune disease, such as rheumatoid arthritis, psoriatic arthritis, type 1 diabetes, vitiligo, and celiac disease
That said, he doesnt recommend anyone stops taking their medication especially as confidence in managing this side effect increases
Exposure to heat, moisture, or repeated freeze-thaw cycles should be minimized to preserve analytical integrity
This combination addresses the primary concern with GLP-1 medications: significant lean tissue loss during aggressive caloric deficits